Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/74803
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ericsson, D. | - |
dc.contributor.author | Standish, A. | - |
dc.contributor.author | Kobe, B. | - |
dc.contributor.author | Morona, R. | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Current Drug Targets, 2012; 13(11):1421-1431 | - |
dc.identifier.issn | 1389-4501 | - |
dc.identifier.issn | 1873-5592 | - |
dc.identifier.uri | http://hdl.handle.net/2440/74803 | - |
dc.description.abstract | The bacterial capsule is a recognized virulence factor in pathogenic bacteria. It likely works as an antiphagocytic barrier by minimizing complement deposition on the bacterial surface. With the continual rise of bacterial pathogens resistant to multiple antibiotics, there is an increasing need for novel drugs. In the Wzy-dependent pathway, the biosynthesis of capsular polysaccharide (CPS) is regulated by a phosphoregulatory system, whose main components consist of bacterial-tyrosine kinases (BY-kinases) and their cognate phosphatases. The ability to regulate capsule biosynthesis has been shown to be vital for pathogenicity, because different stages of infection require a shift in capsule thickness, making the phosphoregulatory proteins suitable as drug targets. Here, we review the role of regulatory proteins focusing on Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli and discuss their suitability as targets in structure-based drug design. | - |
dc.description.statementofresponsibility | Daniel J. Ericsson, Alistair Standish, Bostjan Kobe, and Renato Morona | - |
dc.language.iso | en | - |
dc.publisher | Bentham Science Publishers Ltd. | - |
dc.rights | © 2012 Bentham Science Publishers | - |
dc.source.uri | http://dx.doi.org/10.2174/138945012803530279 | - |
dc.subject | Antibiotic resistance | - |
dc.subject | bacterial pathogens | - |
dc.subject | capsule | - |
dc.subject | drug discovery | - |
dc.subject | protein tyrosine kinase | - |
dc.subject | protein tyrosine phosphatase | - |
dc.subject | Wzy | - |
dc.subject | Bacterial Capsule | - |
dc.subject | capsular polysaccharide (CPS) | - |
dc.subject | bacterial-tyrosine kinases (BY-kinases) | - |
dc.title | Wzy-dependent bacterial capsules as potential drug targets | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.2174/138945012803530279 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Morona, R. [0000-0001-7009-7440] | - |
Appears in Collections: | Aurora harvest 2 Molecular and Biomedical Science publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_74803.pdf | Accepted version | 931.56 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.